At-a-Glance:
| Company |
Asahi Kasei Biomaterial Business Development Department |
|---|
| Specialties |
Cellulose-based products |
|---|
| Mission |
Leveraging 100 years of accumulated cellulose-based chemical technology expertise to provide unique products to the biopharmaceutical and diagnostics industries. |
|---|
| Noteworthy |
Product lines demonstrate the company’s commitment to advancing biotechnology through innovative material solutions. |
|---|
| Location |
Tokyo, Japan |
|---|
Tapping into a century of cellulose chemistry expertise, Asahi Kasei’s Biomaterial Business Development Department develops innovative products for life science applications. Through the design and production of unique cellulose-derived products, Asahi Kasei addresses specific challenges in areas such as cell culture and the development of POCT technologies and devices.
The core strength of the Biomaterial Business Development Department lies in its unique product portfolio based on cellulose materials. These products exemplify the company’s commitment to scientific innovation and its pursuit of solutions that cater specifically to evolving industry needs.
One key offering from the department is BioCradle™, a microcarrier designed for efficient cultivation of adherent cells in stirred culture vessels. This technology is highly useful for applications including vaccine production using Vero cells and the cultivation of mesenchymal stem cells for exosome-based therapeutics. The BioCradle microcarrier is constructed with a cellulose base, and its surface is functionalized with diethylaminoethyl groups. This functionalization creates a positively charged surface favorable for cell adhesion. Additionally, its design features surface pores that allow cells to migrate into the internal structure, which supports the achievement of high-density cultures. This internal migration provides a shelter for cells, particularly benefitting those that are sensitive to shear stress caused by mechanical agitation during culture.
Another notable innovation is NanoAct™, a range of vividly dyed cellulose particles designed to support the development of lateral flow immunoassays (LFIAs). LFIAs are widely used diagnostic tests that require a balance of sensitivity, cost-effectiveness, and multiplexing. NanoAct particles are notable for their strong visible color and the availability of multiple color options, which enhance test performance by making results easier to interpret. The practical design of NanoAct enables reduction in the use of reagents, simplification of test formats, and the potential for clearer and more definitive assay results.
By advancing cellulose chemistry and material functionalization techniques, Asahi Kasei’s Biomaterial Business Development Department exemplifies the translation of foundational chemical know-how into practical applications that aim to make a significant impact in the life sciences.